400-0512-686

News

News
Location:Home >News >News

Lumigenex attened AACC 2017

Poptime:2017-08-24 Page View:2308

The 69th AACC Annual Meeting and Clinical Lab Expo was successfully held from August 1st to August 3rd. As the largest exposition for clinical laboratory products and services,the 69 th AACC Clinical Lab Expo featured 789 exhibitors and covered 246,000 net square feet, also making this the largest show floor in AACC’s history. This dynamic exhibit featured groundbreaking tests from all laboratory medicine disciplines, including mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.


Lumigenex(SuZhou)Co.,Ltd, as the leading brand of POCT, has successfully presented this fantastic event.Our star product LTRIC-300 Time-Resolved fluorescence immunoassay Analyzer, an exquisite handheld  POCT product.With proprietary technology with global IP protection and detection capabilities, allowing enhanced test item capacity, LTRIC-300 represents a change in the innovation of POCT. On the spot, many customers showed great interest in cooperating with us., is used widely in South America, Europe, Middle East, Southeast Asia and many other countries and areas. At the same time, we have received a good feedback from the market.

The newly updated LTRIC-600 Time-Resolved fluorescence immunoassay Analyzer has impressed the customer with, automatic barcode identification, easy-to-use operation and accurate result.


                                                                President Dr. He is communicating with customers


Earlier
April 2014

Lumigenex receives CFDA approval for four POCT immunoassay kits to help physicians quickly and accurately diagnose heart diseases.

March 2014

Lumigenex receives CFDA approval for five immunoassay reagents adaptable to most chemical analyzers.

February 2014

Lumigenex received CFDA approval for time-resolved fluorescence immunochromatographic analyzer.

January 2014

Dr. He Aimin was named "National Thousand Talents Program"

December 2013

Lumigenex access to "high-tech enterprises in Jiangsu Province" title.

September 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment.